Caplin Point Laboratories Ltd (NSE:CAPLIPOINT)

Q2 2026 Caplin Point Laboratories Ltd Earnings Call Transcript

Nov 6, 2025 / 10:30 AM GMT

Release Date Price: ₹2004.4 (+0.46%)

Transcript

Key Points

Positve

Caplin Point Laboratories Ltd (BOM:524742) reported an 11% year-on-year growth in operating revenue, indicating strong financial performance.
The company has achieved a significant milestone with its net worth crossing the 3,000 crore mark.
Caplin Point Laboratories Ltd (BOM:524742) has a robust cash position with cash and cash equivalents standing at 1,334 crores.
The company is expanding its product pipeline with plans to file 11 new products by the next financial year.
Caplin Point Laboratories Ltd (BOM:524742) is exploring strategic acquisitions to enhance its top-line and bottom-line growth.

Negative

The company faces challenges in entering larger geographies due to the time required for product registration and bio studies.
There is a potential risk of commoditization in the generic pharmaceutical market, which could impact margins.
Caplin Point Laboratories Ltd (BOM:524742) is exposed to currency risks due to its geographically diversified operations.
The company has a relatively high receivables period of 117 days, which could impact cash flow.
There is uncertainty regarding the impact of future tariffs on generic products, which could affect the company's cost structure.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CAPL.NS - Caplin Point Laboratories Ltd
Q2 2026 Caplin Point Laboratories Ltd Earnings Call
Nov 06, 2025 / 10:30AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, good day and welcome to the Q2NH1F526 Kaling Point Laboratories conference call hosted by 361 Capital.

As a reminder, all the participant lines will be in the listen-only mode, and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during the conference call, please signal an operator by pressing, then 0 on your touchstone phone.

I now hand the conference over to Julie Meta from 361 Capital.

Thank you and owe it to you, ma'am.

--------------------------------------------------------------------------------
Unidentified_2 [2]
-------------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.